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Abstract
Background: Acute promyelocytic leukemia (APL) accounts for less than 10% of pediatric AML.
Cases of APL in Down syndrome (DS) have been described in the literature rarely and it is rarer
still to find the microgranular variant (M3v) of APL in trisomy 21 patients.
Case presentation: We present a case of a five-year-old female with Down syndrome diagnosed
with acute promyelocytic leukemia (APL). She came to our hospital with bleeding manifestations.
Blood and bone marrow examination revealed promyelocytes showing a few fine granules and
occasional Auer rods. Based on this morphology and cytochemistry, a diagnosis of APL
microgranular variant (M3v) was made.
Conclusion: This case report emphasizes the importance of a high index of suspicion in the
diagnosis of acute promyelocytic leukemia microgranular variant in Down syndrome.
Introduction
Acute myeloid leukemia (AML) comprises approximately
one-fifth of pediatric leukemias [1]; and acute promyelo-
cytic leukemia (APL) accounts for less than 10% of pedi-
atric AML [2]. Trisomy 21 is associated with a 15-fold
increased risk of acute leukemia, with AML occurring
three times more frequently than acute lymphoblastic
leukemia (ALL) in the first 3 years of life. The most com-
mon subtype of AML in Down syndrome (DS) is acute
megakaryoblastic leukemia [3]. Though cases of APL in
DS have been described in the medical literature rarely, it
is rarer still to find the microgranular variant (M3v) of
APL in trisomy 21 patients [4]. Herein, we describe a case
of a five year old child with DS who presented with bleed-
ing and was diagnosed as APL (M3v).
Case presentation
A five-year-old female child, a known case of DS, pre-
sented with a history of gum bleeding, tarry stools and
hematemesis of five days duration. On physical examina-
tion, she was pale and had petechiae, bleeding gums and
hepatomegaly. There was an enlarged submandibular
lymph node. Her coagulogram studies were unremarka-
ble. Serum fibrinogen levels were within normal limits
(2.0 g/l); and tests for fibrin degradation products and D-
dimer were also negative. Hemogram findings were as fol-
lows: Hb 5 g/dl; WBC 80 × 103/l; and platelets 12 × 109/l.
The peripheral smear demonstrated an increased number
of WBCs, neoplastic promyelocytes and occasional blasts
(90%) with high nuclear-cytoplasmic ratio and conspicu-
ous nucleoli. These promyelocytes had markedly lobu-
lated and invaginated nuclei. The cytoplasm of the cells
contained no clearly recognizable granules but showed
occasional Auer rods (Fig 1a). The red cells showed mild
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anisocytosis with a few macrocytes. A bone marrow aspi-
rate and biopsy was performed with the following differ-
ential: 70% promyelocytes which had a morphology
similar to those seen in the peripheral blood; 23% blasts;
5% myelocytes; and 2% lymphocytes. Normal hemat-
opoiesis was suppressed (Fig 1b). The promyelocytes were
strongly positive for myeloperoxidase (MPO) stain (Fig
2). Periodic acid Schiff's stain was predominantly negative
except for fine granular positivity in an occasional promy-
elocyte. Unfortunately, conventional cytogenetic analysis
could not be performed in this case due to unavailability
of fresh blood or marrow sample after the diagnosis, as
the patient left against medical advice. However, immu-
nophenotypically these cells were strongly positive for
anti MPO stain. A trephine biopsy showed hypercellular
marrow infiltrated by sheets of blasts and promyelocytes
and a marked depression of normal hematopoiesis (Fig
3). Based on the morphology and cytochemical analysis,
a diagnosis of AML-M3v was made. All-trans retinoic acid
(ATRA) with chemotherapy was prescribed. However, the
patient left against medical advice. Therefore, the final
outcome could not be ascertained.
Discussion
APL is a subtype of AML in which abnormal promyelo-
cytes predominate. APL accounts for approximately 5–8%
of AML [5]. It differs from other subtypes of AML in that
the patients are often younger. Our case was a 5 year old
female with DS. Most patients of APL present with a pan-
cytopenia rather than an elevated white cell count, how-
ever high WBC count has been seen in AML M3v. Our
index patient had hyperleucocytosis at the time of presen-
tation. AML M3v accounts for approximately 1/3 of APL
cases. It most often presents in pediatric patients. The
cytomorphology of AML M3v blasts is obviously different
from AML M3 blasts, these cells have a non- or hypogran-
ular cytoplasm or contain fine dust-like cytoplasmic
azurophil granules that may not be apparent by light
microscopy. Furthermore, M3v blasts show a typical
bilobed, multilobed or reniform nuclear configuration.
This latter morphologic phenotype, together with missing
granulation, has often resulted in the misleading diagno-
sis of acute monocytic or myelo-monocytic leukemia.
These cells show very strong MPO reaction, as was also
seen in the case under discussion. Both AML M3 and M3v
reveal translocation (15;17) (q22;q12) on cytogenetic
analysis. Unfortunately cytogenetic analysis could not be
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done in the present patient. Immunophenotypically, they
express myeloid phenotype [6]. Although 90% of children
with AML have no known risk factors, a number of predis-
posing constitutional disorders have been found in the
remaining 10% of children. Multiple studies have estab-
lished the incidence of leukemia in DS patients, to be 10-
to 20-fold higher than that in the general population. The
proportion of ALL and AML in patients with DS is similar
to non-DS leukemia patients matched for age. AML in DS
is usually of the FAB M7 sub-type [3]. Only a few cases of
APL associated with trisomy 21 have been published in
the English literature. Singal et al [7] in 1987 reported a
case of a 64-year-old male diagnosed to have APL with tri-
somy 21. Spell et al [4] in 2002 described M3-V in trisomy
21 patient in a 26-year-old Hispanic man. Recently, Kurk-
ijan et al [8] published a case of DS with AML M3 encoun-
tered in an adult. Ours is the fourth reported case of APL
in DS, and possibly the second case of AML-M3 v associ-
ated with DS. To the best of the authors' knowledge no
case of APL in DS in pediatric age group has been
described so far. It is important to report the variant form
of APL, for therapy and prognosis of the patient. Results
from gene profiling suggest that the two morphological
subtypes of APL (M3 and M3v) are clearly separable. The
present case adds a new case of pediatric AML M3v associ-
ated with trisomy 21 to the medical literature.
Conclusion
This case report emphasizes the importance of a high
index of suspicion in the diagnosis of acute promyelocytic
leukemia microgranular variant in Down syndrome
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